Investing.com -- Shares of Chemours (NYSE:CC) climbed 2% in after-hours trading following an upgrade by Mizuho analyst John Roberts from Outperform to Neutral, with a new price target set at $19.00.

RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company (CC – Research Report) yesterday and set a price target of $25.00. The company’s shares closed yesterday at $14.45.

Investing.com -- Shares of Chemours (NYSE:CC) climbed 2% in after-hours trading following an upgrade by Mizuho analyst John Roberts from Outperform to Neutral, with a new price target set at $19.00.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...